-->

Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
10-QQuarterly report which provides a continuing view of a company's financial positionAug 2, 2012View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
4Statement of changes in beneficial ownership of securitiesAug 2, 2012View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventAug 1, 2012View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJul 25, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 11, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 5, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 5, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 5, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 29, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 26, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 6, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 4, 2012View HTMLDownload DOCDownload PDF
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Jun 1, 2012View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJun 1, 2012View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMay 31, 2012View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMay 31, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 31, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 31, 2012View HTMLDownload DOCDownload PDF
8-A12G/AAmendment to a previously filed 8-A12GMay 30, 2012View HTMLDownload DOCDownload PDFDownload XLS
S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersMay 30, 2012View HTMLDownload DOCDownload PDFDownload XLS
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3May 30, 2012View HTMLDownload DOCDownload PDFDownload XLS
S-8 POSPost-effective amendment to an S-8 filingMay 29, 2012View HTMLDownload DOCDownload PDFDownload XLS
3Initial filing by director officer or owner of more than ten percent.May 29, 2012View HTMLDownload DOCDownload PDF
S-8Securities offered to employees pursuant to employee benefit plansMay 25, 2012View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMay 24, 2012View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-50      51-75      76-100      101-125      126-150      151-154

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information